1. Nat. Rev. Urol. doi:10.1038/nrurol.2016.26
Figure 6 68Ga-PSMA–PET–CT of a 74-year-old patient with recurrent prostate cancer (initial Gleason score 7) after radical prostatectomy and local salvage radiotherapy with rising serum PSA value (1.76 ng/ml at the time of assessment)
Figure 6 | 68Ga-PSMA–PET–CT of a 74-year-old patient with recurrent prostate cancer (initial Gleason score 7) after radical prostatectomy and local salvage radiotherapy with rising serum PSA value (1.76 ng/ml at the time of assessment). a | Contrast-enhanced CT shows a mass in the area of the former left seminal vesicle having residual tissue, reactive fibrosis or recurrent disease. b | PET and c | fused PET–CT images demonstrate intense 68Ga-PSMA uptake, indicative of a locally recurrent tumour. Salvage PSMA-radioguided surgery revealed soft-tissue poorly differentiated adenocarcinoma of the prostate (Gleason score 7) including a seminal vesicle with a cribriform carcinoma. PSMA, prostate-specific membrane antigen.
Maurer, T. et al. (2016) Current use of PSMA–PET in prostate cancer management
Nat. Rev. Urol. doi: /nrurol